US Stock Insider Trading | Avanos Medical Discloses 8 Insider Transactions on March 10

K-LinePoet · 2026-03-21T22:54:21+00:00

Avanos Medical disclosed multiple insider transactions in March 2026, with executives primarily making purchases on March 6. The company focuses on medical device solutions, dedicated to meeting healthcare needs.

K-LinePoet

2026-03-21 22:54:21

Abstract generation in progress

On March 10, 2026, Avanos Medical (AVNS) disclosed eight insider transactions. Executive Galovan Scott Michael purchased 5,907 shares on March 6, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
March 10, 2026	Executive	Hurley John Joseph	March 6, 2026	Buy	243	13.79	3,350.97
March 10, 2026	Executive	Galovan Scott Michael	March 6, 2026	Buy	453	13.79	6,246.87
November 19, 2025	Executive	Holbrook Kerr	November 18, 2025	Sell	761	11.01	8,378.61
November 19, 2025	Executive	Holbrook Kerr	November 18, 2025	Sell	100	11.01	1,100.50
November 19, 2025	Executive	Holbrook Kerr	November 18, 2025	Sell	13,800	11.00	152,000.00
November 19, 2025	Executive	Holbrook Kerr	November 18, 2025	Sell	305	11.02	3,361.10
September 9, 2025	Executive	Hurley John Joseph	September 5, 2025	Sell	345	12.66	4,367.70
August 15, 2025	Director	BLACKFORD GARY	August 13, 2025	Buy	20,000	10.98	219,000.00
August 15, 2025	Director	BLACKFORD GARY	August 13, 2025	Buy	40,000	11.00	440,000.00
May 14, 2025	Executive	Greiner Michael	May 13, 2025	Sell	24,200	12.43	301,400.00

[Company Profile]

Avanos Medical, Inc. was originally incorporated in Delaware on February 25, 2014. The company is a medical technology firm focused on providing clinically superior medical device solutions to help patients return to what matters most. The company is dedicated to addressing some of today’s most critical healthcare needs, including providing vital nutritional lifelines from hospitals to homes, reducing opioid use, and assisting patients in transitioning from surgery to recovery. It develops, manufactures, and markets its recognized brands worldwide, maintaining a leading market position across multiple categories in its portfolio.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes